首页> 外文期刊>Cancer gene therapy >miR-15b regulates cisplatin resistance and metastasis by targeting PEBP4 in human lung adenocarcinoma cells
【24h】

miR-15b regulates cisplatin resistance and metastasis by targeting PEBP4 in human lung adenocarcinoma cells

机译:miR-15b通过靶向人肺腺癌细胞中的PEBP4调节顺铂耐药性和转移

获取原文
           

摘要

MicroRNAs (miRNAs) have been identified as important posttranscriptional regulators involved in various biological and pathological processes of cells, but their association with tumor chemoresistance has not been fully understood. We detected miR-15b expression in two lung adenocarcinoma cell lines, A549 and A549/CDDP, and then investigated the effects of miR-15b on the metastasis and the chemosensitivity of cancer cells, using both gain- and loss-of-function studies. The correlation between miR-15b level and chemoresistance was further investigated in clinical lung adenocarcinoma specimens. miR-15b was significantly upregulated in cisplatin-resistant lung adenocarcinoma A549/CDDP cells compared with parental A549 cells. miR-15b regulates epithelial–mesenchymal transition (EMT) and cisplatin resistance in vitro and modulates response of lung adenocarcinoma cells to cisplatin in vivo. Further studies identified phosphatidylethanolamine-binding protein 4 (PEBP4) as a direct and functional target of miR-15b. Small-interfering RNA-mediated PEBP4 knockdown revealed similar effects as that of ectopic miR-15b expression, whereas overexpression of PEBP4 attenuated the function of miR-15b in lung adenocarcinoma cells. Increased miR-15b expression was also detected in tumor tissues sampled from lung adenocarcinoma patients treated with cisplatin-based chemotherapy and was proved to be correlated with low expression of PEBP4, decreased sensitivity to cisplatin and poor prognosis. Our results suggest that upregulation of miR-15b could suppress PEBP4 expression and in turn contribute to chemoresistance of lung adenocarcinoma cells to cisplatin.
机译:MicroRNA(miRNA)已被确定为参与细胞各种生物学和病理过程的重要转录后调节剂,但尚未完全了解它们与肿瘤化学耐药性的关系。我们在两个肺腺癌细胞系A549和A549 / CDDP中检测到miR-15b的表达,然后使用功能获得和丧失功能研究研究miR-15b对癌细胞转移和化学敏感性的影响。在临床肺腺癌标本中进一步研究了miR-15b水平与化学耐药性之间的相关性。与亲本A549细胞相比,在顺铂耐药的肺腺癌A549 / CDDP细胞中miR-15b明显上调。 miR-15b在体外调节上皮-间质转化(EMT)和顺铂耐药性,并在体内调节肺腺癌细胞对顺铂的反应。进一步的研究确定了磷脂酰乙醇胺结合蛋白4(PEBP4)是miR-15b的直接和功能靶标。小干扰RNA介导的PEBP4敲低显示出与异位miR-15b表达相似的作用,而PEBP4的过表达减弱了miR-15b在肺腺癌细胞中的功能。在以顺铂为基础的化学疗法治疗的肺腺癌患者的肿瘤组织中也检测到miR-15b表达增加,并被证明与PEBP4的低表达,对顺铂的敏感性降低和预后不良有关。我们的研究结果表明,miR-15b的上调可抑制PEBP4表达,进而有助于肺腺癌细胞对顺铂的化学耐药性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号